Suchergebnisse - "Xia, Shengli"

PubPharm (36)

1

Immunogenicity and safety of an egg culture-based quadrivalent inactivated non-adjuvanted subunit influenza vaccine in subjects ≥3 years : A randomized, multicenter, double-blind, active-controlled phase III, non-inferiority trial

enthalten in: Vaccine | 2022

von Zhang, Y. | Wang, Y. | Jia, C. | +21

2

Neuroimaging Studies of Chronic Prostatitis/Chronic Pelvic Pain Syndrome

enthalten in: Pain research & management | 2022

von Zhao, Y. | Lin, J. | Dong, Y. | +7

3

Safety and Immunogenicity of an Inactivated COVID-19 Vaccine, WIBP-CorV, in Healthy Children : Interim Analysis of a Randomized, Double-Blind, Controlled, Phase 1/2 Trial

enthalten in: Frontiers in immunology | 2022

von Xia, S. | Duan, K. | Zhang, Y. | +35

4

Safety and immunogenicity of an inactivated COVID-19 vaccine, BBIBP-CorV, in people younger than 18 years : a randomised, double-blind, controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2022

von Xia, S. | Zhang, Y. | Wang, Y. | +35

5

Safety and immunogenicity of a quadrivalent inactivated subunit non-adjuvanted influenza vaccine : A randomized, double-blind, active-controlled phase 1 clinical trial

enthalten in: Vaccine | 2021

von Wang, Y. | Zhang, Y. | Wu, H. | +11

6

Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV : a randomised, double-blind, placebo-controlled, phase 1/2 trial

enthalten in: The Lancet. Infectious diseases | 2021

von Xia, S. | Zhang, Y. | Wang, Y. | +29

7

Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes : Interim Analysis of 2 Randomized Clinical Trials

enthalten in: JAMA | 2020

von Xia, S. | Duan, K. | Zhang, Y. | +34

CommentIn: JAMA. 2020 Sep 8;324(10):943-945. - PMID 32789500

8

Safety, immunogenicity, and lot-to-lot consistency of live attenuated varicella vaccine in 1-3 years old children : a double-blind, randomized phase III trial

enthalten in: Human vaccines & immunotherapeutics | 2019

von Huang, L. | Chen, Z. | Hu, Y. | +11

9

A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly

enthalten in: Human vaccines & immunotherapeutics | 2019

von Huang, L. | Wang, L. | Li, H. | +10

10

Molecular characterization and analysis of high-level multidrug-resistance of Shigella flexneri serotype 4s strains from China

enthalten in: Scientific reports | 2016

von Yang, C. | Li, P. | Zhang, X. | +19